MétaCan
Menu
Back to cohort
Record W3007003780 · doi:10.1183/13993003.02026-2019

Predictors of progression in systemic sclerosis patients with interstitial lung disease

2020· review· en· W3007003780 on OpenAlexafffund
Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K. Danoff, Christopher P. Denton, Jörg H. W. Distler, Anna‐Maria Hoffmann‐Vold, Sindhu R. Johnson, Ulf Müller Ladner, Vanessa Smith, Elizabeth R. Volkmann, Toby M. Maher

Bibliographic record

VenueEuropean Respiratory Journal · 2020
Typereview
Languageen
FieldMedicine
TopicSystemic Sclerosis and Related Diseases
Canadian institutionsUniversity of TorontoMount Sinai Hospital
FundersItalfarmacoCSL BehringNational Institute for Health and Care ResearchGalápagosU.S. Department of Veterans AffairsApellis PharmaceuticalsCanadian Institutes of Health ResearchMedacFonds Wetenschappelijk OnderzoekGalectoF. Hoffmann-La RocheSanofiGlaxoSmithKlineCelgeneActelion PharmaceuticalsPfizerBiogenGilead SciencesBayerEli Lilly and CompanyBristol-Myers SquibbAstraZenecaGenentechVlaamse regeringBritish Lung FoundationBoehringer IngelheimAmgenGlenmark PharmaceuticalsAcceleron
KeywordsMedicineInterstitial lung diseaseLungDiseaseScleroderma (fungus)Lung diseasePathologyInternal medicine

Abstract

fetched live from OpenAlex

Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in SSc.There are no valid biomarkers to predict the occurrence of SSc-ILD, although auto-antibodies against anti-topoisomerase I and several inflammatory markers are candidate biomarkers that need further evaluation. Chest auscultation, presence of shortness of breath and pulmonary function testing are important diagnostic tools, but lack sensitivity to detect early ILD. Baseline screening with high-resolution computed tomography (HRCT) is therefore necessary to confirm an SSc-ILD diagnosis. Once diagnosed with SSc-ILD, patients' clinical courses are variable and difficult to predict, although certain patient characteristics and biomarkers are associated with disease progression. It is important to monitor patients with SSc-ILD for signs of disease progression, although there is no consensus about which diagnostic tools to use or how often monitoring should occur. In this article, we review methods used to define and predict disease progression in SSc-ILD.There is no valid definition of SSc-ILD disease progression, but we suggest that either a decline in forced vital capacity (FVC) from baseline of ≥10%, or a decline in FVC of 5-9% in association with a decline in diffusing capacity of the lung for carbon monoxide of ≥15% represents progression. An increase in the radiographic extent of ILD on HRCT imaging would also signify progression. A time period of 1-2 years is generally used for this definition, but a decline over a longer time period may also reflect clinically relevant disease progression.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.291
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations239
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Respiratory JournalSame topicSystemic Sclerosis and Related DiseasesFrench-language works237,207